Diclofenac Sodium Solution
NDC 43386-016
Product Information
Diclofenac Sodium is a ANDA-approved product labeled by Lupin Pharmaceuticals,inc.. Diclofenac is used to relieve pain, swelling (inflammation), and joint stiffness caused by arthritis. It is supplied as a pink solution for topical administration. This product entry covers the primary NDC 43386-016 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
ORANGE (C48331)
Code Structure Chart
Product Details
What is NDC 43386-016?
What are the uses of this product?
What are Active Ingredients of this product?
- DICLOFENAC SODIUM 16.05 mg/mL - A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DICLOFENAC SODIUM (UNII: QTG126297Q)
- DICLOFENAC (UNII: 144O8QL0L1) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- DIMETHYL SULFOXIDE (UNII: YOW8V9698H)
- ALCOHOL (UNII: 3K9958V90M)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- GLYCERIN (UNII: PDC6A3C0OX)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 857700 - diclofenac sodium 1.5 % Topical Solution
- RxCUI: 857700 - diclofenac sodium 15 MG/ML Topical Solution
- RxCUI: 857700 - diclofenac sodium 1.5 % (as diclofenac sodium 16.05 MG/ML) Topical Solution
- RxCUI: 857700 - diclofenac sodium 16.05 MG per 1 ML Topical Solution
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.